|
1.
|
|
8 p, 1.3 MB |
The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer : Its Correlation with the Magnetic Resonance Imaging Prostate Volume
/
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Picola, Natàlia (Hospital Universitari de Bellvitge) ;
Muñoz-Rodríguez, Jesús (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Paesano, Nahuel (Clinica Creu Blanca) ;
Ruiz-Plazas, Xavier (Hospital Universitari de Tarragona Joan XXIII) ;
Muñoz-Rivero, Marta V. (Hospital Universitari Arnau de Vilanova) ;
Celma, Ana (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
García-de Manuel, Gemma (Hospital Universitari de Girona Doctor Josep Trueta) ;
Miró, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
To relate the prostate volume category (PVC) assessed with digital rectal examination (DRE)-small, median, and large-and the prostate volumes (PVs) assessed with magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS). [...]
2024 -  10.5534/wjmh.230028
The world journal of men's health, Vol. 42 (january 2024) , p. 441-448
|
|
|
2.
|
|
9 p, 440.0 KB |
Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer Detection
/
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Picola, Natàlia (Hospital Universitari de Bellvitge) ;
Muñoz-Rodríguez, Jesús (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Paesano, Nahuel (Clínica Creu Blanca) ;
Ruiz-Plazas, Xavier (Hospital Universitari Joan XXIII de Tarragona) ;
Muñoz-Rivero, Marta V. (Hospital Universitari Arnau de Vilanova) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Manuel, Gemma García-de (Hospital Universitari de Girona Doctor Josep Trueta) ;
Miró, Berta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Abascal, Jose Maria (Parc de Salut MAR de Barcelona)
Concerns exist regarding the effects of 5-alpha reductase inhibitors (5-ARIs) on multipa-rametric magnetic resonance imaging (mpMRI) and clinically significant prostate cancer (csPCa) detection. Our objective is to analyze the effect of 5-ARI on the prostate imaging-reporting and data system (PI-RADS) distribution and csPCa and insignificant PCa (iPCa) detection. [...]
2024 - 10.3390/biom14020193
Biomolecules, Vol. 14 (february 2024)
|
|
|
3.
|
|
12 p, 597.5 KB |
A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic Biopsies
/
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Picola, Natàlia (Hospital Universitari de Bellvitge) ;
Muñoz-Rodríguez, Jesús (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Paesano, Nahuel (Clínica Creu Blanca (Barcelona, Catalunya)) ;
Ruiz-Plazas, Xavier (Hospital Universitari Joan XXIII de Tarragona) ;
Muñoz-Rivero, Marta V. (Hospital Universitari Arnau de Vilanova) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
García-de Manuel, Gemma (Hospital Universitari de Girona Doctor Josep Trueta) ;
Aisian, Ignacio (Hospital Clínic i Provincial de Barcelona) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Abascal, Jose Maria (Universitat Pompeu Fabra)
The primary objective of this study was to analyse the current accuracy of targeted and systematic prostate biopsies in detecting csPCa. A secondary objective was to determine whether there are factors predicting the finding of csPCa in targeted biopsies and, if so, to explore the utility of a predictive model for csPCa detection only in targeted biopsies. [...]
2023 - 10.3390/cancers15184543
Cancers, Vol. 15 (september 2023)
|
|
|
4.
|
|
22 p, 3.7 MB |
Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
/
Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ;
Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ;
Triquell, Marina (Hospital Universitari Vall d'Hebron) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Regis, Lucas (Hospital Universitari Vall d'Hebron) ;
Mast, Richard (Hospital Universitari Vall d'Hebron) ;
de Torres, Inés M. (Hospital Universitari Vall d'Hebron) ;
Semidey, María E. (Hospital Universitari Vall d'Hebron) ;
Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Fàbrega-Santamaria, Anna (Hospital Universitari Vall d'Hebron) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron) ;
Esteban, Luis M (Universidad de Zaragoza) ;
Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Magnetic resonance imaging (MRI)-associated prostate-specific antigen density (mPSAD) and MRI predictive models have been proposed for improving the selection of candidates for prostate biopsy among men with suspected prostate cancer (PCa). [...]
2022 - 10.3390/cancers14102374
Cancers, Vol. 14 (may 2022)
|
|
|
5.
|
|
18 p, 1.7 MB |
Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer : A Systematic Review
/
Triquell, Marina (Hospital Universitari Vall d'Hebron) ;
Campistol, Miriam (Hospital Universitari Vall d'Hebron) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Regis, Lucas (Hospital Universitari Vall d'Hebron) ;
Cuadras, Mercè (Hospital Universitari Vall d'Hebron) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron) ;
Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ;
Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Magnetic resonance imaging (MRI) has allowed the early detection of PCa to evolve towards clinically significant PCa (csPCa), decreasing unnecessary prostate biopsies and overdetection of insignificant tumours. [...]
2022 - 10.3390/cancers14194747
Cancers, Vol. 14 (september 2022)
|
|
|
6.
|
|
14 p, 2.2 MB |
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand
/
Morote Robles, Juan (Hospital Universitari Vall d'Hebron) ;
Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ;
Triquell, Marina (Hospital Universitari Vall d'Hebron) ;
Campistol, Miriam (Hospital Universitari Vall d'Hebron) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Regis, Lucas (Hospital Universitari Vall d'Hebron) ;
Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron) ;
Mendez, Olga (Hospital Universitari Vall d'Hebron) ;
Esteban, Luis M (Universidad de Zaragoza) ;
Trilla Herrera, Enrique (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Early detection of PCa (PCa) has evolved towards clinically significant PCa (csPCa) after the spread of pre-biopsy multiparametric magnetic resonance imaging (mpMRI). However, PCa suspicion remains based on prostate-specific antigen (PSA) elevation and/or abnormal digital rectal examination (DRE). [...]
2022 - 10.3390/cancers14205100
Cancers, Vol. 14 (october 2022)
|
|
|
7.
|
|
9 p, 282.6 KB |
Multiparametric MRI for Staging of Prostate Cancer : A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy
/
Triquell, Marina (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Regis, Lucas (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Winkler, Mathias (Charing Cross Hospital) ;
Valdés, Nicolás (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Cuadras, Mercè (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Celma, Ana (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Planas, Jaques (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Trilla Herrera, Enrique (Universitat Autònoma de Barcelona. Departament de Cirurgia)
The correct identification of extracapsular extension (ECE) of prostate cancer (PCa) on multiparametric magnetic resonance imaging (mpMRI) is crucial for surgeons in order to plan the nerve-sparing approach in radical prostatectomy. [...]
2022 - 10.3390/cancers14163966
Cancers, Vol. 14 Núm. 16 (august 2022) , p. 3966
|
|
|
8.
|
|
13 p, 1.7 MB |
The Barcelona Predictive Model of Clinically Significant Prostate Cancer
/
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ;
Triquell, Marina (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Celma, Ana (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Regis, Lucas (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Escobar, Manel (Hospital Universitari Vall d'Hebron) ;
Mast, Richard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ;
Semidey, María E. (Universitat Autònoma de Barcelona. Departament de Ciències Morfològiques) ;
Abascal, Jose Maria (Parc de Salut MAR de Barcelona) ;
Solà Belda, Carles (Parc de Salut MAR de Barcelona) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Salvador Hidalgo, Daniel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Santamaría, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron) ;
Esteban, Luis M. (Universidad de Zaragoza. Departamento de Matemática Aplicada) ;
Trilla Herrera, Enrique (Universitat Autònoma de Barcelona. Departament de Cirurgia)
Magnetic-resonance-imaging-based predictive models (MRI-PMs) improve the MRI prediction of clinically significant prostate cancer (csPCa) in prostate biopsies. Risk calculators (RC) provide easy individual assessment of csPCa likelihood. [...]
2022 - 10.3390/cancers14061589
Cancers, Vol. 14 (march 2022)
|
|
|
9.
|
|
10 p, 1.3 MB |
Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer : a systematic review
/
Cuadras, Mercè (Hospital Universitari Vall d'Hebron) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron) ;
Celma, Ana (Hospital Universitari Vall d'Hebron) ;
Regis, Lucas (Hospital Universitari Vall d'Hebron) ;
de Torres, Inés (Hospital Universitari Vall d'Hebron) ;
Semidey, M. Eugenia (Hospital Universitari Vall d'Hebron) ;
Trilla, Enrique (Hospital Universitari Vall d'Hebron) ;
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Universitat Autònoma de Barcelona
Lymph node (LN) status is a key prognostic factor in the decision-making process of different cancer entities, including prostate cancer (PCa). Sectioning and haematoxylin and eosin (H&E) staining technique remain the gold standard for the evaluation of LN metastases despite some limitations, especially low sensitivity in detecting an accurate tumour burden within the LN, as well as a subjective and time-consuming result. [...]
2022 - 10.1186/s12885-022-09355-0
BMC Cancer, Vol. 22 (april 2022)
|
|
|
10.
|
|
10 p, 555.0 KB |
The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
/
Morote Robles, Juan (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Campistol, Miriam (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Celma, Ana (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Regis, Lucas (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
de Torres, Inés (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Semidey, María E. (Universitat Autònoma de Barcelona. Departament de Cirurgia) ;
Roche, Sarai (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Mast, Richard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Santamaría, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Planas, Jacques (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Trilla Herrera, Enrique (Universitat Autònoma de Barcelona. Departament de Cirurgia)
To analyze how Proclarix is valuable to appropriately select candidates for multiparametric magnetic resonance imaging (mpMRI) and derived biopsies, among men with suspected prostate cancer (PCa). Proclarix is a new marker computing the clinically significant PCa (csPCa) risk, based on serum thosmbospondin-1, cathepsin D, prostate-specific antigen (PSA) and percent free PSA, in addition to age, that has been developed in men with serum PSA 2 to 10 ng/mL, prostate volume ≥35 mL, and normal digital rectal examination (DRE). [...]
2021 - 10.5534/wjmh.210117
The world journal of men's health, Vol. 40 (december 2021) , p. 270-279
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
